Skip to main content

Pulmonary Drug Delivery Devices Market to Receive Overwhelming Hike in Revenues by 2027

7 min read

Transparency Market Research (TMR) has published a new report titled, ‘Pulmonary Drug Delivery Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global pulmonary drug delivery devices market was valued at US$ 36,159.9 Mn in 2018 and is projected to expand at a CAGR of 2.7% from 2019 to 2027.

Overview

Pulmonary Drug Delivery Devices are the devices used primarily for the delivery of the locally acting drugs directly to their site of action, these devices are oftenly used for the management of asthma, COPD, chronic bronchitis and other respiratory diseases. Nebulizers, Metered Dose Inhaler, Dry Powder Inhaler are major pulmonary drug delivery devices with an innovative approach than the conventional inhalers. Rising trend of the targeted drug delivery through pulmonary route, improving patient acceptance and compliance for a non-invasive systemic route are few factors propelling the growth of the market.

Request for Report Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48993

North America dominated the global pulmonary drug delivery devices market in 2018 and the trend is anticipated to continue during the forecast period. Acceptance and awareness of technological advancements, rise in COPD incidences, increase in the geriatric population, and strong reimbursement policies. Moreover, insurance coverage for pulmonary drug delivery devices and huge availability of these instruments to the patients is another key factor for its growth in the coming years.

Asia pacific is likely to be major lucrative market for the growth of the pulmonary drug delivery devices. Merger and acquisition amongst companies and launching of innovative products for managing various respiratory conditions are estimated to drive the market of the pulmonary drug delivery devices. Rise in smoking, leading to COPD and other respiratory condition, and increase in disposable income are key factors for the increasing adaption of pulmonary drug devices. Moreover, a rise in the geriatric population in Japan and China, growing patient acceptance due to improved consistency of delivery and product stability drives the demand for pulmonary drugs delivery devices.

Rise in respiratory disease such as Asthma and COPD, and Increasing Smoker Population to Drive Market

The number of smokers is increasing globally. The U.S. has seen a decline in the percentage of people smoking; however, there are still 40 million adults who smoke and 20 million will die prematurely unless they quit. Also, exposure to secondhand smoke raises complications for people suffering from asthma and COPD. According to the American Lung Association, exposure to secondhand smoke can cause more than 202,000 asthma flare-ups among children each year. According to the WHO, tobacco accounts for over 6 million deaths each year; more than 600,000 of these are non-smokers exposed to second-hand smoke. Such alarming statistics indicate that the habit of smoking and increase in number of smokers are likely to propel the pulmonary drug delivery devices market.

According to WHO, COPD is the fourth-leading cause of death globally, with approximately 2.75 million deaths per annum. WHO predicts that COPD would be the third-leading cause of death by 2030.In United States, around more than 16 million people are suffering from COPD condition and this statistics likely to drive the need of the pulmonary drug delivery devices. As per Centers for Disease Control and Prevention (CDC), 1 in 13 people likely to have asthma which accounted for 25 million Americans to have asthma. Amongst 25 million Americans, 7.7% adults and 8.4% of children possess asthma.

Request for Analysis of COVID-19 Impact on Pulmonary Drug Delivery Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=48993

Dry Powder Inhaler Segment to Dominate Market

Based on product type, the global pulmonary drug delivery devices market has been dry powder inhaler, metered dose inhaler, and nebulizers. Dry powder inhaler segment is further segmented into single dose inhalers, and multi-dose inhalers. Metered dose inhaler is further classified into manually actuated pressurized inhaler, and breath-actuated pressurized inhaler. Nebulizers is also further bifurcated into jet nebulizer, ultrasonic wave nebulizers, and vibrating mesh nebulizers.

The dry powder inhaler segment held major share of the global pulmonary drug delivery devices market in 2018 and the trend is anticipated to continue during the forecast period. The attributable factors are attributed to its effective, efficient, and environmentally friendly way of delivering drugs to the lung. Moreover, uniform distribution of the drug, small dose variation, and good flow ability, adequate physical stability in the device before use and good performance in terms of emitted dose and fine particle fraction.

Asthma Segment to Hold Largest Market Share and Cystic Fibrosis to be Highly Lucrative Segment

In terms of application, the global pulmonary drug delivery devices market has been divided into asthma, COPD, cystic fibrosis, and Others.

The asthma segment held a largest market share in the year 2018 and Cystic fibrosis segment is expected to grow at highest CAGR during forecast period. As per research, severe asthma is prevalent in adults and highly common in the children. According to Global Asthma Network, asthma kills around 1000 people, every day, and affects around 339 million people, which are mostly from low- and middle-income countries.

As per Cystic Fibrosis News Today, with higher rate of incidence in the U.S., an estimated 30,000 people suffer from cystic fibrosis. Furthermore, according to research, approx. 1,000 new cases of cystic fibrosis are diagnosed in the U.S. each year. In Europe, the incidence of cystic fibrosis in newborns is around 2000 to 3000 and in Asia Pacific, the disease is highly undiagnosed and the prevalence in the region is very rare. These statistics are estimated to boost the cystic fibrosis market to propel in coming years.

Buy Pulmonary Drug Delivery Devices Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=48993<ype=S

North America to Dominate Global Market

In terms of region, the global pulmonary drug delivery devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pulmonary drug delivery devices market in 2018, followed by Europe.

North America accounted for major share of the global pulmonary drug delivery devices market in 2018, followed by Europe owing to increase in prevalence of respiratory diseases, such as asthma, COPD, cystic fibrosis, etc.  in the region. Moreover, favorable reimbursement policies, presence of key players, merger & acquisitions, augment the demand of pulmonary drug delivery devices in the market.

The pulmonary drug delivery devices market in Asia Pacific is anticipated to expand at a highest CAGR from 2019 to 2027. This can be attributed to increasing adoption of various pulmonary drug delivery devices, growing incidences of the asthma, COPD and other respiratory conditions. Medial tourism, rapid economic growth in developing economies such as India, China, Indonesia and others are another attributable factors for the market growth in the region.

Competitive Landscape

The global pulmonary drug delivery devices market is fragmented in terms of number of players. Key players in the global market include Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., MannKind Corporation, F. Hoffmann-La Roche Ltd., Mylan N.V., Omron Corporation, 3M Healthcare, Sunovion Pharmaceuticals, Inc., Koninklijke Philips N.V., PARI GmbH, Nypro Healthcare Inc. (Jabil Circuit Inc.) and other prominent players.

Companies strive to maintain their leading position in the market by adopting various business strategies such as merger & acquisition, launch of technically advanced products, and expansion strategy enabled companies to expand their product line and strengthen geographic presence across globe.

More Trending Reports by Transparency Market Research –

Life Science Reagents Market: http://www.prnewswire.com/news-releases/technological-advancements-to-drive-significant-growth-in-the-life-science-reagents-market-from-2019-to-2027-states-tmr-301025999.html

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Upper Respiratory Tract Infection Treatment Market: Lucrative Opportunities

5 min read

Upper respiratory tract infection (URTI) is a medical condition caused by acute infection that involves parts of the upper respiratory tract such as larynx or pharynx, sinuses, and nose. Pharyngitis, sinusitis, laryngitis, tonsillitis, common cold, and otitis media are some of the most common upper respiratory tract disorders. Upper respiratory tract disorders are caused due to the direct invasion of the mucus membrane by bacteria or viruses.

Read Report Overview – https://www.transparencymarketresearch.com/upper-respiratory-tract-infection-treatment-market.html

Sneezing, rhinorrhea, nasal congestion, sore throat, nasal discharge, cough, fever, malaise, and odynophagia are some of the most common symptoms observed in patients diagnosed with upper respiratory tract disorders. Some other symptoms of the disease are headaches, hyposmia, foul breath, sinus pain, shortness of breath, vomiting, diarrhea, nausea, conjunctivitis, and body ache.

Upper respiratory tract disorders can be treated with antibiotics and decongestants. Acetaminophen, diphenhydramine, ibuprofen, dextromethorphan, guaifenesin, codeine, dexamethasone, and prednisone are some of the antibiotics that are prescribed to patients suffering from upper respiratory tract disorders. Phenylephrine, oxymetazoline, and pseudoephedrine are some of the most commonly prescribed decongestants for the treatment of upper respiratory tract disorders. Antibiotics are rarely used as a treatment option for upper respiratory tract disorders as they are associated with many side effects and also can initiate secondary infections and bacterial resistance.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58905

The global upper respiratory tract infection treatment market is expected to expand substantially, due to an increase in the incidence of respiratory disorders across the globe. Additionally, constantly changing climatic conditions due to global warming and pollution have further accentuated the risk for developing upper respiratory tract disorders. Moreover, changing lifestyle of people and increase in medical insurance coverage are expected to boost demand for upper respiratory tract infection treatment market.

Increase in awareness among people about their health and rise in expenditure on personal hygiene are likely to augment the global upper respiratory tract infection treatment market. Favorable reimbursement scenario and advanced medical infrastructure in developed countries are responsible for the robust growth of the upper respiratory tract infection treatment market. However, side effects of NSAIDs are expected to impact the growth of this market. Moreover, rise in the incidence of allergy after topical treatment of drugs is also estimated to hinder the upper respiratory tract infection treatment market.

Request for Analysis of COVID-19 Impact on Upper Respiratory Tract Infection Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=58905

The global upper respiratory tract infection treatment market can be segmented based on treatment, distribution channel, and region. Based on treatment, the market can be classified into topical treatment and drug treatment. Topical treatment segment can be further sub-segmented into cough suppressant, nasal decongestant, and others. The drug treatment segment can be further divided into antibiotics, NSAID, and others. In terms of distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and online sales.

Based on region, the global upper respiratory tract infection treatment market can be categorized into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The market in each geography is sub-divided into specific countries such as the U.S., Canada, Germany, the U.K., Brazil, China, India, Japan, and GCC countries. North America dominated the global upper respiratory tract infection treatment market in 2017 because of high incidence of infections in the U.S. According to a study conducted in the U.S., 25% people are suffering from upper respiratory tract infections. The infections are the most common reasons for doctor visits. The market in developing regions such as Asia Pacific is expected to expand at a high growth rate as compared to that in developed regions due to an increase in the geriatric population in the region.

Pre Book Upper Respiratory Tract Infection Treatment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=58905<ype=S

Some of the major players in the upper respiratory tract infection treatment market are Merck & Co., Inc., Alcon, Inc., Collegium Pharmaceutical, Inc., Verona Pharma Plc, GlaxoSmithKline plc, Teva Pharmaceuticals, Pfizer Inc., Hospira,Inc.,  and Sandoz, Inc.. In order to gain a competitive advantage in the industry, major players are actively involved in various growth strategies. Collaborations, partnerships, agreements, and new product launches are some of the important strategies that are applied by market players.

More Trending Reports by Transparency Market Research –

Voice Prosthesis Devices Market: https://www.biospace.com/article/voice-prosthesis-devices-market-indwelling-voice-prosthesis-devices-segment-accounted-for-a-major-market-share/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Respiratory Syncytial Virus Diagnostic Testing Market - Brief Analysis by Top Key Players

4 min read

Respiratory syncytial virus (RSV) causes infection of respiratory system (lungs and breathing passage). It may also affect heart and immune system resulting in more serious illnesses (e.g. tachypnea, cyanosis).Premature infants (30-40 days) and children (less than 2 year of age) are at the highest risk of this infection.

Read Report Overview – https://www.transparencymarketresearch.com/respiratory-syncytial-virus-diagnostic-testing.html

According to the U.S. Centre for Disease Control and Prevention (CDC), RSV is the common cause of bronchiolitis or pneumonia in the children under one year of age in the United States. Each year 75,000 to 125,000 children are hospitalized due to RSV infections. This Infection can result from the direct (i.e. kiss, touch or shake hands with infected person) or indirect contact (i.e. contact with sneeze, cough or blows of infected person)with the infected person.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2065

Mild headache, runny nose, cough and sore throat are some of the common symptoms of RSV viral infections. Diagnosis of these infections is facilitated by specific tests like polymerase chain reaction assay, molecular probes, chest radiography. Physicians also administer intubation (breathing tube), mechanical ventilation or some antibiotics (like palivizumab) in order to treat the patients with RSV infections.

Increasing incidences of childhood pneumonia, acts as one of the major factors to drive the growth of RSV diagnostic testing market. According to the data enumerated by World Health Organization (WHO), in 2010, approximately 1.1 million people in the United States were hospitalized with pneumonia and 50,000 people died from this disease.

Request for Analysis of COVID-19 Impact on Respiratory Syncytial Virus Diagnostic Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2065

In addition, crowded population and unhygienic environment (dirty premises, unhygienic eating places) may increase the chances of RSV infection thereby resulting in increased need and demand for effective RSV diagnostic tests. However, high number of other pathogens that may cause similar symptoms of respiratory illness and lack of availability of specific treatment options to curb this infection may restrain the growth of this market.

Geographically, North America and Europe dominate the global RSV diagnostic testing market due to increasing patient population suffering from respiratory syncytial virus. According to the U.S. CDC, approximately 50,000 deaths are noted due to pneumonia in the United States in year of 2012.In addition, Asia-Pacific countries such as India and China, South East Asian countries are the emerging regions for global RSV diagnostic testing market due to high prevalence of these diseases (i.e. pneumonia, bronchitis) in these regions and increasing healthcare awareness.

Pre Book Respiratory Syncytial Virus Diagnostic Testing Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=2065<ype=S

Some of the key players in this industry are Abbott Laboratories, Beckman Coulter, Ortho-Clinical Diagnostics, bioMerieux, F. Hoffman-La Roche, Ltd., Bio-Rad Laboratories, Inc., DiaSorin S.p.A , Novartis Diagnostics, Becton Dickson  company and Thermo Fisher Scientific among others.

More Trending Reports by Transparency Market Research –

Arterial Stents Market: https://www.biospace.com/article/arterial-stents-market-introduction-of-new-product-variants-makes-coronary-stents-dominant/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

 

Respiratory Humidification Market: Business Overview and Global Development Trends

6 min read

Global Respiratory Humidification Market: Snapshot

The global market for respiratory humidification has been witnessing a steady upswing in its valuation. The efficiency of respiratory humidification solutions in decreasing the need for invasive therapies and various other complicated interventions in patients is boosting their demand substantially, leading to a significant rise of this market.

Read Report Overview – https://www.transparencymarketresearch.com/respiratory-humidification-market.html

Over the coming years, the market will continue to experience high growth on the grounds of the increasing awareness among consumers pertaining to their benefits and the ease of usage they offer to patients of all ages. Respiratory humidification solutions find extensive application in the medical and healthcare industry in supplying warm moisture and breathing gas to patients, particularly to infants.

An emergent therapy involving high flow humidifiers, named high flow humidification therapy (HfT), is witnessing a wide ranging uptake among medical professional for the treatment of patients with multiple respiratory disorders. This, as a result, has bolstered the worldwide market for respiratory humidification solutions substantially. These solutions not only provide patients with respiratory support but also increase the oxygen concentration in their blood, which is likely to fuel their demand across the world in the years to come. The presence of a large pool of players characterizes the competitive landscape of the global respiratory humidification market, which is expected to intensify over the next few years.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26672

Respiratory humidification is a process of warming, purification, and humidification of the respiratory gas artificially. The lung tissues start getting damaged due to dryness of the organs when the natural humidification fails. Thus, respiratory humidification is carried out for mechanically ventilated patients. An artificial respiration causes the epithelial mucus layer to become more viscous in a short time, impairing the ciliary function inside the nose. Thus to prevent such complications, the loss of heat and moisture are compensated by the humidification process. The humid air is provided to the nasal mucosa at 37 degrees Celsius (room temperature), with adjusted 100% relative humidity to maintain mucociliary clearance for long time.

Rising need and demand for neonatal care products and increasing geriatric population at a global level are the major factors which are expected to drive the market of respiratory humidification during the forecast period. However, stringent government regulations and the damage caused to the nasal mucosa during the invasive procedure are expected to restrain the market of respiratory humidifiers during the forecast period.

Request for Analysis of COVID-19 Impact on https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=26672

The global respiratory humidifiers market is segmented based on product type, end-user, and region. On the basis of product type, the market is segmented into active humidifiers, passive humidifiers, and respiratory humidifiers accessories. The active humidifiers segment is further segmented into nebulizers and evaporators. The evaporators subsegment includes ultrasonic humidifiers and electronic humidifiers. The passive humidifiers segment is divided into invasive ventilation, noninvasive ventilation, and high-flow nasal cannula (HFNC). The nebulizers sub-segment accounted for high market shares in 2016 owing to the ease of administration of humidified air by nebulizers and rising demand for handheld and cost-effective humidifiers. However, the invasive ventilation subsegment is projected to generate a high market revenue during the forecast period, which is attributed to the low risk of mucociliary damage by the procedure and rising prevalence of respiratory disorders in neonates. Incorporation of innovative features such as alarm management in the instrument and increasing investment in R&D by local and regional players are estimated to boost the market growth for invasive ventilations during the forecast period.

Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and homecare settings. The hospitals segment accounted for a significant market share in 2016 due to the high cost of invasive humidifiers and positive reimbursement policies. This segment is expected to continue to dominate the market during the forecast period owing to rising prevalence of respiratory disorders such as COPD and asthma and increasing geriatric population in developed countries of North America at an alarming rate.

Pre Book Respiratory Humidification Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=26672<ype=S

Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America generated the highest revenue in 2016 due to the introduction of invasive humidifiers in the market, which adjust the temperature and humidity of gas according to patients’ need. The insufficient warmed-up air provided by the traditional humidifiers, which doesn’t carry enough moisture particles damages the epithelial layer of nasal mucosa. It is a major factor boosting the market growth of respiratory humidifiers in Asia Pacific. However, North America is expected to continue to dominate the market during the forecast period owing to the rising incidence of the mucociliary impairment in neonates.

Key players operating in the global Respiratory Humidification Market are WILAmed GmbH, Fisher & Paykel Healthcare, Respironics, Inc., ResMed, Teleflex Incorporated, DeVilbiss Healthcare, Smiths Medical, Flexicare Medical Limited, and Humi.AIDE.

More Trending Reports by Transparency Market Research –

Glycated Hemoglobin Testing Market: https://www.biospace.com/article/glycated-hemoglobin-testing-market-point-of-care-segment-to-dominate-the-other-test-segments-in-the-global-market/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Hearing Aids Market Set to Garner Staggering Revenues by 2024

5 min read

A report by Transparency Market Research on the global hearing aids market states that the market has an oligopolistic landscape. The reason behind this is the dominance of just six prominent players. Cumulatively, these players accounted for 98% total growth of the market in 2015.

This dominance of the players makes the entry of newcomers extremely difficult in the market. Even if a company manages to enter the market, it is at high risk of being overthrown by the incumbent players. Further, high initial investment is another factor that restricts a new player from entering the hearing aids market.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4952

The players who have a stronghold over the market are William Demant Holding Group, Widex A/S, Sonova Holding AG, Siemens Healthcare, Starkey, and GN ReSound.

Geriatric Population – Hearing Aids Market: Major Growth Factor

People with age above 50 have tendency to develop hearing problems. The report states that growing number of geriatric population in the U.S., India, China, and various European countries is purchasing hearing aids. Rise in sales of various hearing aids technologies in the regions is one of the major factors driving growth of the global hearing aids market from 2016 to 2024. Moreover, rising awareness of about variety of hearing aids available in the market among old people is also stimulating the growth of the market.

Request for Analysis of COVID19 Impact Hearing Aids Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4952

4.5% CAGR from 2016 to 2024 in Multibillion-Dollar Market Indicates Enormous Prospects

Transparency Market Research’s report suggests that the global hearing aids market is expected to witness 4.5% CAGR during the forecast period of 2016 to 2024. It also states that the market that worth US$ 4.7 bn in 2015 is expected to reach the value of US$7 bn by the end of 2024. The market is experiencing the projected growth, mainly on the back of rising hearing aid services provided by various companies that design and develop hearing aids products. Since deafness or hearing loss can happen at any age to anybody. Organizations are developing hearing aids devices which are accessible by every age group around the world. The development of products for various peoples of various ages is another factor driving the growth for the global hearing aids market. Additionally, better availability of the products to customers is also a prominent factor driving the growth of the market in the forecast period of 2016 to 2024.

Benefits from Support and Subsidy by Governments

Governments across the globe are offering huge support to the companies that are developing hearing aid products. These governments are focused on preventing deafness in their respective countries. Subsequently they have introduced numerous initiatives to raise the awareness about the condition, products, and treatments. These initiatives stimulates the players to develop and unveil products to meet wide range of demands of populations.

For instance, in 2017, president Trump signed Over the Counter (OTC) Hearing Aid Act which aims to improve the adoption of hearing aid devices for the patients lacking prescription of a healthcare practitioner. With this act the U.S. Government expects to support a large number of patients suffering from healing loss.

Buy Hearing Aids Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=4952<ype=S

Adult Hearing Aids Segment Held 95% of Market Share

On the basis of end users, the global hearing aids market is bifurcated into two segments, the pediatric and adult hearing aids. Of these, the adult hearing aids segment is the largest shareholder in the global hearing aids market. According to the report, the segment accounts for 95% of total market share in 2015. This prominence of the segment is driven by the preference of the customer, affordability, flexibility of use, and low maintenance.

More Trending Reports by Transparency Market Research –

Alpha Mannosidosis Market: https://www.biospace.com/article/alpha-mannosidosis-market-to-expand-at-a-cagr-of-9-9-percent-from-2019-to-2027/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

 

Website: https://www.transparencymarketresearch.com/

UV Light Disinfection Systems Market Shares, Strategies and Opportunities 2024

7 min read

UV Light Disinfection Systems: Introduction

·         UV light disinfection systems are non-touch disinfection device used to kill various infectious pathogens present on medical devices, health care equipment, and health care facilities such as operating rooms and patient wards

·         These systems use high intensity ultraviolet light-C (UV-C) lamp. The UV-C light is germicidal in nature i.e., it destroys the DNA of the bacteria, viruses, and fungi and prevents them from multiplying, thereby preventing spread of infections in health care set-ups. These lamps use the wavelength of 100 nm to 280 nm on the electromagnetic spectrum.

·         This method is used as complementary method to improve the disinfection after other disinfection methods have been used for decontamination of the medical devices, equipment, and surfaces.

·         UV light disinfection has several advantages over other methods. These systems sanitize all the surfaces in a room at once, achieve desired levels of disinfection, require least manpower, and prevent the usage of harmful and hazardous chemicals

·         There are two primary types of UV light disinfection systems: mercury UV-bulbs that emit continuous dose of UV-C light and pulsed xenon ultraviolet devices

Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report

UV Light Disinfection Systems Market: Key Drivers

·         The global UV light disinfection systems market is projected to be driven by high prevalence and increase in incidence rates of hospital-acquired infections across the globe

·         According to the Centers for Disease Control and Prevention (CDC), every year, more than 1.7 million hospitalized patients acquire health care-associated infections and around 98,000 patients succumb to it.

·         Rise in burden on health care facilities to reduce the number of health care-associated infections and rise in demand for effective & safety disinfection technologies are the major factors anticipated to boost the growth of the market during the forecast period

·         Moreover, rise in the number of hospitalizations due to various chronic and acute disorders, increase in the geriatric population in developed countries, and surge in number of hospitals & health care institutions across the globe are expected to contribute to growth of the global market during the forecast period

·         However, high cost of UV light disinfection systems is likely to hamper the growth of global UV light disinfection systems market

Looking for exclusive market insights from business experts? Request a Custom Report here

Portable Segment to Dominate Global Market

·         In terms of product, the global UV light disinfection systems market can be classified into standalone, portable, wall-mounted, and compact. The portable segment is projected to dominate the global market during the forecast period.

·         Portable UV light systems can be easily transferred from one ward to other wards. Hence, these systems have significant demand in large health care institutions.

·         Comparatively large volume of portable UV light disinfection systems, low cost, and easy availability are factors anticipated to fuel the growth of the segment during the forecast period

Pulsed Xenon to be Attractive Segment

·         Based on light source, the global market can be bifurcated into pulsed xenon and mercury. Pulsed xenon is expected to be a highly attractive segment during the forecast period.

·         Mercury UV systems use low-pressure gas bulbs that emit narrow band of the UV-C spectrum at wavelength of 254 nm. Xenon UV systems use xenon lamps and emit light at variable wavelengths ranging from 200 nm to 320 nm. It emits light in both UV-B and UV-C spectrums.

 

Request for Analysis of COVID19 Impact on UV Light Disinfection Systems Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77862

Automatic Systems to be Highly Lucrative Segment

·         In terms of type, the global market can be categorized into automatic, semiautomatic, and analog. The automatic segment is likely to present significant opportunities for new players planning to enter the market.

Hospitals to be Highly Attractive Segment

·         Based on end-user, the global UV light disinfection systems market can be divided into hospitals & ambulatory surgery centers, clinics, academic & research institutes, and biopharma & medical device industries. The hospitals segment is projected to dominate the global market during the forecast period.

·         Comparatively large number of hospitals, increase in hospitalizations due to various chronic as well as acute medical disorders, and surge in number of new hospitals in emerging countries such as Brazil, Mexico, India, and China are attributed to the segment’s dominance during the forecast period.

Asia Pacific UV Light Disinfection Systems Market to Grow at Rapid Pace

·         In terms of region, the global UV light disinfection systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

·         North America is projected to dominate the global market during the forecast period. Well-established health care infrastructure, high health care funding, rise in number of hospitalizations, and large base of UV light disinfection device manufacturers are attributed to the region’s dominance during the forecast period.

·         The Centers for Disease Control and Prevention (CDC) has estimated that by the mid of July 2020, there will be around 1,000 to 15,000 new COVID-19 hospitalizations per day in the U.S.

·         The UV light disinfection systems market in Asia Pacific is expected to expand at the fastest CAGR during the forecast period. Rapid growth of the market in the region is attributed to increase in number of hospitals & ambulatory surgery centers, improving health care infrastructure, and high prevalence of hospital-acquired infections in China and India.

·         High growth rate of the health care industry, easy access to health care facilities, and increase in investments in health care by leading players in Asia Pacific are likely to fuel the growth of the market in Asia Pacific

 

Purchase UV Light Disinfection Systems Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77862<ype=S

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Counterfeit Drug Detection Device Market to Flourish with an Impressive CAGR by 2024

5 min read

Global Counterfeit Drug Detection Device Market: Snapshot

The global counterfeit drug detection device market is all set to show upward graph of revenues during the forecast period of 2019 to 2027. Key reason supporting this growth is the increased use of counterfeit drug detection device from all across the world. Counterfeit drug detection device is gaining traction owing to its ability to offer superior quality services.

An upcoming research report from TMR on the counterfeit drug detection device market discusses about all vital factors impacting positively or negatively on market growth. This report provides reliable data on volume, shares, potential growth avenues, and key players working in the market for counterfeit drug detection device. Thus, this report is intended to give all important insights of the counterfeit drug detection device market for the forecast period of 2019 to 2027.

The global counterfeit drug detection device market is segmented on the basis of various key factors such as technology, modality, application, and region. Based on technology, the market for counterfeit drug detection device is classified into microfluidic, infrared and near infrared spectroscopy, Raman spectroscopy, rapid chemical testing, RFID technology, and other technologies.

For Right Perspective & Competitive Insights on this Report, Request for a Sample

Global Counterfeit Drug Detection Device Market: Growth Dynamics

The global counterfeit drug detection device market is expanding on the back of plethora of reasons. The world is witnessing shifting focus on on-dosage security rather than packaging security of drugs. This factor is stimulating the growth of the global counterfeit drug detection device market. In recent years, the government bodies of many countries in the world have started implementing stringent regulations related to counterfeit drug detection. As a result, the market for counterfeit drug detection device is witnessing remarkable growth avenues. Apart from this, growing emphasis on superior surveillance in supply chain industry will drive the market growth in the upcoming period.

Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report

Global Counterfeit Drug Detection Device Market: Competitive Analysis

The global counterfeit drug detection device market is moderately fragmented in nature. Key reason behind this situation is presence of numerous well-established players. At the same time, it denotes that the competitive landscape of the market for counterfeit drug detection device is extremely intense. Enterprises are executing diverse strategies to maintain their leading position in the counterfeit drug detection device market.

Request for Analysis of COVID19 Impact on Counterfeit Drug Detection Device Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77856

One of the key trending strategies in the counterfeit drug detection device market is increased research and development activities. This strategy is helping players to improve the quality of their products. Apart from this, several vendors are focused on regional expansion. All these activities depict that the market for counterfeit drug detection device will grow at rapid speed in the upcoming period.

Global Counterfeit Drug Detection Device Market: Regional Assessment

The global counterfeit drug detection device market is spread across five key regions, namely, North America, Europe, South America, Asia Pacific, and Middle East and Africa. Of them, North America is one of the leading regions of the market for counterfeit drug detection device. The region is expected to continue its dominance in the upcoming years owing to plethora of reasons. Increased use of drug testing services for investigational procedures, growing government initiatives against substance abuse, growing number of toxicological laboratories, and increasing inclination toward drug testing at the workplace are some major factors fueling the growth of the counterfeit drug detection device market in North America.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

Purchase Counterfeit Drug Detection Device Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77856<ype=S

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Single-use Negative Pressure Wound Therapy Devices Market Value Projected to Expand by 2024

6 min read

Single-use Negative Pressure Wound Therapy Device: Introduction

·         Negative pressure wound therapy (NPWT) devices are class II devices (FDA) that consist of drainage tubing, vacuum pump, and wound dressing set, and need electricity to maintain their use

·         Negative pressure wound therapy (NPWT) is indicated for the treatment of wounds. The application of suction promotes wound healing and removes fluids such as bodily fluids, wound exudate, irrigation fluids, or infectious materials.

·         Negative pressure wound therapy can be indicated for use on sub-acute, acute, chronic, dehisce, and traumatic wounds, pressure ulcers, diabetic ulcers, skin grafts, and flaps

·         Single-use negative pressure wound therapy devices include powered pump, battery, and dressing without the canister. These devices are suitable for the treatment of low-to-moderate exuding wounds. The single-use negative pressure wound therapy devices deliver up to 80 mm Hg pressure.

Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report

Key Drivers of Global Single-use Negative Pressure Wound Therapy Device Market

·         Increase in health awareness among individuals and rise in popularity of negative pressure wound therapy for the treatment of chronic and acute wounds are projected to fuel the growth of the global single-use negative pressure wound therapy devices market during the forecast period

·         Surge in the number of people with chronic and acute wounds is anticipated to drive the single-use negative pressure wound therapy devices market from 2020 to 2030

For Right Perspective & Competitive Insights on Single-use Negative Pressure Wound Therapy Devices Market, Request for a Sample

Ulcers Segment to Account for Major Share of Global Market

·         In terms of application, the global single-use negative pressure wound therapy devices market can be bifurcated into ulcers and burn wounds

·         The ulcers segment is expected to dominate the global single-use negative pressure wound therapy devices market during the forecast period

·         Ulcers such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers are commonly treated with single-use negative pressure wound therapy devices. Increase in incidence and prevalence of ulcer wounds is likely to drive the segment during the forecast period.

 

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77848

Hospitals to be Highly Attractive Segment

·         Based on end-user, the global single-use negative pressure wound therapy devices market can be classified into hospitals, clinics, ambulatory surgical centers, and others

·         The hospitals segment is projected to account for major share of the global single-use negative pressure wound therapy devices market by 2030

·         The segment’s dominance can be attributed to large patient pool with various types of ulcers and burns treated in hospitals

North America to Dominate Global Single-use Negative Pressure Wound Therapy Devices Market

·         In terms of region, the global single-use negative pressure wound therapy devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

·         North America is anticipated to dominate the global market during the forecast period. Rise in demand for high quality medical technologies, increase in education & awareness about wound care therapies, and presence of key players in countries such as the U.S. are expected to drive the single-use negative pressure wound therapy devices market in the region.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request for Analysis of COVID19 Impact on Single-use Negative Pressure Wound Therapy Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77848

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Purchase Single-use Negative Pressure Wound Therapy Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77848<ype=S

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

 

Multiplexed Diagnostics Market to Record an Exponential CAGR by 2024

6 min read

Transparency Market Research (TMR) has published a new report titled, ‘Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.

Overview

·         Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively, in biochemical substances, cells of an organism, or an organic sample for disease diagnosis

·         Multiplexed diagnostics screen multiple analytes in a single cycle of assay procedure. Though single plex assays are widely available in the market, they fail to yield results for multiple analytes in a single cycle of assay process, and thus when multiple analytes are needed to be screened, cost and turnaround time of single plex assay is higher as compared to multiplexed assay.

·         Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases is the major factor to drive the global market.

·         North America dominated the global multiplexed diagnostics market in 2018 and anticipated to dominate during the forecast period.

 

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1719

Significant private and public funding for genomics and personalized medicine to Drive Market

·         Growing demand for automated equipment and multifaceted analytical strategies is the major driver for the growth of global multiplexed diagnostics market.

·         Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases and Increasing prevalence of cancer and infectious diseases are some of the major factors responsible for the growth of global multiplexed diagnostics market

·         For instance, as per WHO 2010 data, Breast cancer is one of the most common causes of mortality among females, accounting for 25% of total cancer cases and 15% of cancer mortality across the world (WHO, 2010).

·         Moreover significant private and public funding for genomics and personalized medicine is also fuelling the growth of global multiplexed diagnostics market.

Medium Density Multiplexed Assays Segment to Dominate Market

·         Based on technology, the global multiplexed diagnostics market has been segmented into Very High Density Multiplexed Assays, High Density Multiplexed Assays, Medium Density Multiplexed Assays, Low Density Multiplexed Assays, and Next Generation Sequencing

·         Medium Density Multiplexed Assays segment is accounted for major market share in 2018 and is expected to dominate throughout the forecast period owing to increasing use in genetic research.

·         Increasing emerging diseases that need new diagnosis tests and new drug development create demand for high density multiplexed assays

Cardiac Diseases- More Lucrative Application Segment

·         Based on application, the global multiplexed diagnostics market has been divided into Infectious Disease Diagnostic, oncology, autoimmune diseases, cardiac diseases, allergies, and others

·         Oncology segment dominated the global market in 2018 due to Product developments that enable smooth, fast procedure for both the physician and patient, and increase in incidence of diseases associated with breast cancer, colorectal cancer, and prostate cancer

·         Cardiac diseases segment is more promising segment during the forecast period owing to rising prevalence of cardiac diseases and development of important biomarkers for cardiac disease detection

 

Request for Analysis of COVID19 Impact on Multiplexed Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1719

Academic research institutes Segment- Lion Market Share

·         Based on end-user, the global multiplexed diagnostics market has been segmented into academic research institutes, hospitals, diagnostic laboratories, pharmaceutical companies, and clinical research organizations

·         Academic research institutes is accounted for major market share in 2018. Increasing research projects in the field of genetic engineering is the key factor driving the segment.

North America to Dominate Global Market

·         In terms of region, the global multiplexed diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

·         North America accounted for major share of the global multiplexed diagnostics market in 2018. Increasing use of multiplexed diagnostics in academic and research institutes, large number of people with oncology and infectious diseases, several market players in the U.S., technological advancements, extensive R&D practices, and increasing awareness about the diagnosis and treatment are likely to boost market growth in the U.S.

·         For instance, the University of California San Francisco (UCSF) has seven PCR installations for its academic research

·         The multiplexed diagnostics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be ascribed to growing aging population, high incidence of various diseases, and increased research activities in the region.

 

Purchase Multiplexed Diagnostics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1719<ype=S

Competitive Landscape

·         The global multiplexed diagnostics market is consolidated as few players hold major market share in global market.

·         Key players include Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Abbott Laboratories, among others

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Alcoholic Hepatitis Therapeutics Market to Witness Exponential Growth by 2024

6 min read

Alcoholic Hepatitis Therapeutics Market: Introduction

According to the report, the global alcoholic hepatitis therapeutics market was valued at US$ 623.6 Mn in 2019 and is projected to expand at a CAGR of 6% from 2020 to 2030. Alcoholic hepatitis is a liver infection caused due to frequent and high consumption of alcohol. Fat that builds up in liver cells can lead to inflammation and scarring of the liver. The infection can be mild or severe. A patient may need a liver transplant if he does not receive treatment or stop consuming alcohol during the early stages. Different types of therapeutics are used in the treatment of alcoholic hepatitis, including corticosteroids, hemorrheologic agents, and anabolic steroids. The growth of the global alcoholic hepatitis therapeutics market can be ascribed to increase in prevalence of the alcoholic liver disease and rise in rate of consumption of alcohol across the globe.

North America dominated the global alcoholic hepatitis therapeutics market in 2019. This trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early new product adoption, high prevalence rate of alcoholic hepatitis, and presence of major players are estimated to drive the alcoholic hepatitis therapeutics market in North America. Asia Pacific is likely to be a highly lucrative region of the global alcoholic hepatitis therapeutics market. It is projected to expand at a fast-paced CAGR during the forecast period.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12209

Increase in Prevalence of Alcoholic Liver Disease and Rise in Alcohol Consumption Rate to Drive Global Market

Increase in the number of patients afflicted with the alcoholic liver disease across the globe is a key factor driving the global alcoholic hepatitis therapeutics market. Around 88,000 people succumb to alcohol-related diseases annually, making alcohol the fourth leading preventable cause of death in the U.S. Rise in the rate of consumption of alcohol across the globe, especially in developed countries such as the U.S., is expected to boost the market in the near future. The use of alcohol varies throughout the world; the U.S. and Europe record the highest usage of alcohol. Around 67.3% of the population in the U.S. consumes alcohol in the U.S; of this, 7.4% meets the criteria for alcohol abuse.

Strong product pipeline is also anticipated to propel the global alcoholic hepatitis therapeutics market during the forecast period. For instance, Generon Pharmaceutical Technology (Shanghai) Co., Ltd. has an innovative product, F-652, in phase 2 of clinical trial.                  

Request for Analysis of COVID19 Impact on Alcoholic Hepatitis Therapeutics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=12209

Corticosteroids Treatment to Dominate Alcoholic Hepatitis Therapeutics Market

Based on treatment, the global alcoholic hepatitis therapeutics market has been divided into corticosteroids, hemorrheologic agents, anabolic steroids, and others. The corticosteroids segment dominated the global alcoholic hepatitis therapeutics market in 2019. This trend is projected to continue during the forecast period. Corticosteroids are considered the first line of treatment in the management of alcoholic hepatitis. Thus, the segment accounts for significant share of the global alcoholic hepatitis therapeutics market.

Corticosteroids was followed by the hemorrheologic agents segment in terms of market share in 2019. Various clinical trials are being conducted to establish the efficacy of pentoxifylline in managing severe alcoholic hepatitis. This is augmenting the hemorrheologic agents segment.

Mild to be Highly Lucrative Application Area of Alcoholic Hepatitis Therapeutics Market

In terms of application, the global alcoholic hepatitis therapeutics market has been bifurcated into mild and severe/chronic. The mild segment accounted for a prominent share of the global alcoholic hepatitis therapeutics market in 2019, owing to rise in awareness about the ill effects of alcohol and early diagnosis of the disease.

Hospital Pharmacies to be Major Distribution Channel

In terms of distribution channel, the global alcoholic hepatitis therapeutics market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment led the global alcoholic hepatitis therapeutics market in terms of revenue in 2019. The trend is expected to continue during the forecast period. Rapid increase in the number of hospitals and a wide range of services available in multispecialty hospitals are likely to boost the segment during the forecast period. Rise in the number of patients opting for retail pharmacies, due to a large number of product brands available at discounted prices at these pharmacies, is estimated to drive the retail pharmacies segment during the forecast period.

North America to Dominate Alcoholic Hepatitis Therapeutics Market

In terms of region, the global alcoholic hepatitis therapeutics market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global alcoholic hepatitis therapeutics market in 2019. It was followed by Europe. Significant share of North America can be ascribed to the increase in the number of people with alcoholic hepatitis, new product launches, and presence of major players in the region. Furthermore, high consumption of alcohol, poor diet, and obesity are some of the common factors boosting the market in the region.

Purchase Alcoholic Hepatitis Therapeutics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=12209<ype=S

The alcoholic hepatitis therapeutics market in Asia Pacific is anticipated to expand at a fast-paced CAGR from 2020 to 2030. This can be ascribed to the presence of developing economies with commercial hubs, expanding business organizations, growing awareness about alcoholic hepatitis, improving health care infrastructure, and rising investments by companies in their technical aspects.

Competition Landscape of Alcoholic Hepatitis Therapeutics Market

The global alcoholic hepatitis therapeutics market is fragmented in terms of number of players. Key players operating in the global market include Gilead Sciences, Inc., Sanofi, Generon Pharmaceutical Technology (Shanghai) Co., Ltd., Immuron Ltd., and Intercept Pharmaceuticals, Inc.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/